Related Experiment Video
Updated: Dec 4, 2025
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
Published on: May 29, 2017
Evaluation of the potassium channel tracer [18F]3F4AP in rhesus macaques
Nicolas J Guehl1, Karla M Ramos-Torres1, Clas Linnman2
1Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Abstract:
Demyelination causes slowed or failed neuronal conduction and is a driver of disability in multiple sclerosis and other neurological diseases. Currently, the gold standard for imaging demyelination is MRI, but despite its high spatial resolution and sensitivity to demyelinated lesions, it remains challenging to obtain specific and quantitative measures of molecular changes involved in demyelination. To understand the contribution of demyelination in different diseases and to assess the efficacy of myelin-repair therapies, it is critical to develop new in vivo imaging tools sensitive to changes induced by demyelination. Upon demyelination, axonal K+ channels, normally located underneath the myelin sheath, become exposed and increase in expression, causing impaired conduction. Here, we investigate the properties of the K+ channel PET tracer [18F]3F4AP in primates and its sensitivity to a focal brain injury that occurred three years prior to imaging. [18F]3F4AP exhibited favorable properties for brain imaging including high brain penetration, high metabolic stability, high plasma availability, high reproducibility, high specificity, and fast kinetics. [18F]3F4AP showed preferential binding in areas of low myelin content as well as in the previously injured area. Sensitivity of [18F]3F4AP for the focal brain injury was higher than [18F]FDG, [11C]PiB, and [11C]PBR28, and compared favorably to currently used MRI methods.
Insights
A new PET tracer, [18F]3F4AP, shows promise for imaging demyelination in neurological diseases. This tracer can detect changes in K+ channels associated with myelin damage, offering a sensitive tool for research and therapy assessment.
Area of Science:
- Neuroscience
- Radiochemistry
- Medical Imaging
Background:
- Demyelination, a hallmark of neurological diseases like multiple sclerosis, impairs neuronal conduction and causes disability.
- Current imaging methods like MRI struggle to provide specific molecular insights into demyelination.
- Increased expression and exposure of axonal K+ channels occur during demyelination, impacting nerve signal transmission.
Purpose of the Study:
- To evaluate the properties and sensitivity of the novel positron emission tomography (PET) tracer [18F]3F4AP for imaging demyelination.
- To assess the tracer's ability to detect molecular changes related to demyelination in vivo.
Main Methods:
- Investigated the pharmacokinetic and imaging properties of [18F]3F4AP in primates.
- Assessed the tracer's sensitivity to a focal brain injury with prior demyelination.
- Compared the performance of [18F]3F4AP with other PET tracers ([18F]FDG, [11C]PiB, [11C]PBR28) and MRI.
Main Results:
- [18F]3F4AP demonstrated excellent brain penetration, metabolic stability, reproducibility, specificity, and fast kinetics.
- The tracer preferentially bound to areas with reduced myelin content and a history of focal brain injury.
- [18F]3F4AP exhibited higher sensitivity for detecting the brain injury compared to other PET tracers and favorably compared to MRI.
Conclusions:
- [18F]3F4AP is a promising PET tracer for in vivo imaging of demyelination and associated molecular changes.
- Its sensitivity and specificity offer potential for understanding disease mechanisms and evaluating myelin repair therapies.
![Autoradiographic Measurements of [14C]-Iodoantipyrine in Rat Brain Following Central Post-Stroke Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F53947.jpg&w=3840&q=50)